ArticleAntioxidants (Basel, Switzerland)2022

Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo.

Rakan Radi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.